Literature DB >> 17337226

Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade.

Zeina A Kanafani1, Ghenwa K Dakdouki, Khalil I El-Chammas, Shaker Eid, George F Araj, Souha S Kanj.   

Abstract

OBJECTIVES: Previous studies from Lebanon have shown Gram-negative organisms to be the predominant agents in febrile neutropenic patients. The objective of this study was to evaluate the most current epidemiological trends among patients with neutropenic fever.
METHODS: This prospective observational cohort study, the largest to date in the country, was conducted at the American University of Beirut Medical Center between January 2001 and December 2003, with the objective of describing the characteristics of patients with neutropenic fever and to assess temporal trends.
RESULTS: We included 177 episodes of neutropenic fever. The most common underlying malignancy was lymphoma (42.4%). Gastrointestinal and abdominal infections were predominant (31.6%) and 23.7% of cases represented fever of unknown origin. Gram-negative organisms were responsible for 78.8% (26/33) of bloodstream infections compared to 33.3% (11/33) with Gram-positive organisms. The in-hospital mortality rate in this study (12.1%) was considerably lower than in previous years.
CONCLUSIONS: Gram-negative organisms are persistently predominant in our center. In a developing country like Lebanon with limited resources, lower mortality rates commensurate with worldwide reports were successfully achieved in this high-risk patient population. Protocols and guidelines should be adapted to the characteristics of individual institutions to ensure delivery of appropriate care to febrile neutropenic patients.

Entities:  

Mesh:

Year:  2007        PMID: 17337226     DOI: 10.1016/j.ijid.2006.12.008

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  17 in total

1.  Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia.

Authors:  Fekade Bruck Sime; Uwe Hahn; Morgyn S Warner; Ing Soo Tiong; Michael S Roberts; Jeffrey Lipman; Sandra L Peake; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Can complications in febrile neutropenia be predicted? Report from a developing country.

Authors:  Sapna Oberoi; Anirban Das; Amita Trehan; Pallab Ray; Deepak Bansal
Journal:  Support Care Cancer       Date:  2017-06-11       Impact factor: 3.603

3.  Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India.

Authors:  Indranil Ghosh; Vinod Raina; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Sanjay Thulkar; Arti Kapil
Journal:  Med Oncol       Date:  2011-02-20       Impact factor: 3.064

4.  Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections.

Authors:  Yishu Tang; Qian Cheng; Qing Yang; Jing Liu; Di Zhang; Wei Cao; Qingxia Liu; Tianyi Zhou; Huiqi Zeng; Li Zhou; QinJin Wang; Huan Wei; Xin Li
Journal:  Infection       Date:  2018-05-16       Impact factor: 3.553

5.  Etiology and clinical course of febrile neutropenia in children with cancer.

Authors:  Hana Hakim; Patricia M Flynn; Katherine M Knapp; Deo Kumar Srivastava; Aditya H Gaur
Journal:  J Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.289

6.  Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols.

Authors:  Manju Panghal; Vivek Kaushal; Sangeeta Kadayan; Jaya Parkash Yadav
Journal:  BMC Oral Health       Date:  2012-07-20       Impact factor: 2.757

Review 7.  Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.

Authors:  Mical Paul; Dafna Yahav; Assaf Bivas; Abigail Fraser; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

8.  Descriptive analysis of sepsis in a developing country.

Authors:  Gilbert Abou Dagher; Mothana Saadeldine; Rana Bachir; Dina Zebian; Ralphe Bou Chebl
Journal:  Int J Emerg Med       Date:  2015-06-06

9.  Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.

Authors:  Rima Moghnieh; Nour Estaitieh; Anas Mugharbil; Tamima Jisr; Dania I Abdallah; Fouad Ziade; Loubna Sinno; Ahmad Ibrahim
Journal:  Front Cell Infect Microbiol       Date:  2015-02-12       Impact factor: 5.293

10.  Febrile neutropenia: outline of management.

Authors:  Sapna Oberoi; Renu Suthar; Deepak Bansal; R K Marwaha
Journal:  Indian J Pediatr       Date:  2012-11-22       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.